Howard Fillit - Co-Founder and Chief Science Officer @ Alzheimer's Drug Discovery Foundation

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title Co-Founder and Chief Science Officer
Primary Organization
Alzheimer's Drug Discovery Foundation

Location New York, New York, United States
Regions Greater New York Area, East Coast, Northeastern US
Gender Male

Investor Type
obfuscated
obfuscation

Facebook View on Facebook
LinkedIn View on LinkedIn
X (Twitter) View on X

Howard Fillit is based out of New York, New York, and is the Co-Founder and Chief Science Officer of Alzheimer's Drug Discovery Foundation. Howard previously worked at New York Life Insurance Company as a Corporate Medical Director for Medicare. Howard Fillit attended Cornell University. Howard Fillit has received the Award for The Rita

Hayworth.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Circular Genomics	Alzheimer's Drug Discovery Foundation	Yes	Grant - Circular Genomics	obfuscated obfuscation
obfuscated obfuscation	Modulo Bio	Alzheimer's Drug Discovery Foundation	Yes	Seed Round - Modulo Bio	obfuscated obfuscation
obfuscated obfuscation	GLX Analytix	Alzheimer's Drug Discovery Foundation	Yes	Venture Round - GLX Analytix	obfuscated obfuscation
obfuscated obfuscation	Imeka	Alzheimer's Drug Discovery Foundation	Yes	Grant - Imeka	obfuscated obfuscation
obfuscated obfuscation	APRINOIA Therapeutics	Alzheimer's Drug Discovery Foundation	Yes	Venture Round - APRINOIA Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Astrocyte Pharmaceuticals	Alzheimer's Drug Discovery Foundation	—	Series B - Astrocyte Pharmaceuticals	obfuscated obfuscation
obfuscated obfuscation	Therini Bio	Alzheimer's Drug Discovery Foundation	—	Series A - Therini Bio	obfuscated obfuscation
obfuscated obfuscation	Superfluid Dx	Alzheimer's Drug Discovery Foundation	Yes	Grant - Superfluid Dx	obfuscated obfuscation
obfuscated obfuscation	Quanterix	Alzheimer's Drug Discovery Foundation	Yes	Grant - Quanterix	obfuscated obfuscation
obfuscated obfuscation	Optina Diagnostics	Alzheimer's Drug Discovery Foundation	Yes	Series A - Optina Diagnostics	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Howard Fillit

has

current jobs including

Co-Founder and Chief Science Officer

Alzheimer's Drug Discovery Foundation

Clinical Professor of Geriatric Medicine and Palliative Care, Medicine & Neuroscience

Icahn School of Medicine at Mount Sinai

, and

Clinical Professor of Geriatrics, Medicine and Neuroscience

Icahn School of Medicine at Mount Sinai

. Additionally,

Howard Fillit

has had

past jobs including

Corporate Medical Director for Medicare

New York Life Insurance

Alzheimer's Drug Discovery Foundation Co-Founder and Chief Science OfficerJan 1998
Icahn School of Medicine at Mount Sinai Clinical Professor of Geriatric Medicine and Palliative Care, Medicine & Neuroscience1987
Icahn School of Medicine at Mount Sinai Clinical Professor of Geriatrics, Medicine and Neuroscience

Organization Name	Title At Company	Start Date	End Date
New York Life Insurance	Corporate Medical Director for Medicare	1995	1998
The Rockefeller University	Team Member	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Howard Fillit

is the

Scientific Advisory Board

Oryzon Genomics SA

Oryzon Genomics SA Scientific Advisory Board

Related Hubs

Hub Name	CB Rank (Hub)
Northeastern US Companies With Less Than $10M in Revenue (Top 10K)	860
Greater New York Area Companies With Less Than $10M in Revenue (Top 10K)	2,297
City of New York Companies With Less Than $1B in Revenue (Top 10K)	4,299
Northeastern US Venture Capital Investors	5,917
City of New York Companies With Less Than $50M in Revenue (Top 10K)	4,829
City of New York Biotechnology Companies	50,788
New York Companies With Fewer Than 100 Employees (Top 10K)	1,733
Venture Capital Investors with Investments in Greater New York Area	1,798
City of New York Venture Capital Investors	11,746
Biotechnology Companies With Less Than $500M in Revenue (Top 10K)	1,935